- /
- Supported exchanges
- / US
- / BIAF.NASDAQ
bioAffinity Technologies, Inc. (BIAF NASDAQ) stock market data APIs
bioAffinity Technologies, Inc. Financial Data Overview
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get bioAffinity Technologies, Inc. data using free add-ons & libraries
Get bioAffinity Technologies, Inc. Fundamental Data
bioAffinity Technologies, Inc. Fundamental data includes:
- Net Revenue: 6 162 K
- EBITDA: -10 067 672
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get bioAffinity Technologies, Inc. Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-03-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
bioAffinity Technologies, Inc. News
New
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?
bioAffinity Technologies, Inc. BIAF investors have been experiencing some short-term gains lately, despite the stock’s bumpy ride in recent months. Shares of the diagnostics company specializing in ...
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change iSpecimen Inc. 186,331,747 0.43...
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?
The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine continue to reshape how diseases are detected and managed. Within this landscape...
bioAffinity Technologies launches $1.8M direct financing
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) has entered into definitive agreements for the purchase and sale of 720,000 shares of common stock, par value $0.007 p...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.